bpc-157 fda warning letter FDA's Overreach on Compounded Peptides fda warning letter bpc-157 unapproved

Breakthrough BPC-157 arginate formulas that are highly stable, bioavailable, and long-acting have great therapeutic potential

Product Specifications: Composition: Water for Injection, USP with 0.9% (9 mg/mL) Benzyl Alcohol, NF (bacteriostatic preservative) Volume: 30mL per sterile vial Container Type: Type I borosilicate glass vial with sterile rubber closure and aluminum overseal pH: 4.5 7.0 (per USP monograph) Osmolality: Hypotonic (approximately 0 mOsm/kg) Sterility Assurance Level: 10 (terminal steam sterilization) Bacterial Endotoxin: Bacterial Endotoxins Test Particulate Matter: Complies with USP Particulate Matter specifications FOR RESEARCH USE ONLY

Betriebsblindheit kennen wir

[35] Women who are pregnant, or planning to be pregnant, must consult their physician regarding the use of lipotropic injections for weight loss